ABBV.NYSEAbbvie INC

Form 4: AbbVie Director Edward J. Rapp Reports Stock Transactions

Sentiment:

Statement of Changes in Beneficial Ownership


AbbVie Inc. director Edward J. Rapp has reported transactions involving restricted stock units and common stock, reflecting changes in beneficial ownership.

Summary

  • Edward J. Rapp, a Director at AbbVie Inc., reported the acquisition of 1,118 restricted stock units (RSUs) on May 8, 2026.
  • These RSUs were awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program and will be settled in shares of common stock upon separation from service, death, or a change in control.
  • Following these transactions, Rapp's total holdings include 45,964 shares of common stock.
  • The filing also notes that 10,388 shares previously held indirectly by a spouse are now held directly by Rapp.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider stock transactions and awards rather than significant strategic shifts or performance indicators.

Positives

  • Director Rapp acquired restricted stock units, indicating continued alignment with the company's long-term performance.
  • The total beneficial ownership of common stock remains substantial at 45,964 shares.

Risks

  • The RSUs are subject to vesting conditions tied to separation from service, death, or a change in control, which could impact the timing of actual share ownership.
  • Potential for future sales of common stock by management or directors could impact share price.

Future Outlook

The restricted stock units will be settled in shares of AbbVie common stock on the earlier of the director's separation from service, death, or the occurrence of a change in control.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into the holdings and activities of company directors and officers. These filings are crucial for investors seeking to understand insider sentiment and potential future stock movements.

Stakeholder Impact

  • Shareholders gain transparency into director's equity holdings and potential future share movements.
  • Employees may view director stock awards as a sign of confidence in the company's future.

Next Steps

  • Vesting and settlement of restricted stock units upon the occurrence of specific events (separation from service, death, or change in control).

Key Dates

DateDescription
05/08/2026Transaction Date for acquisition of restricted stock units and common stock.
05/12/2026Date of signature for the Form 4 filing.

Keywords

AbbVie Inc., ABBV, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, Director Transactions, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.